However, there was a notable trend towards altered beta-diversity between the two patient groups, though not statistically significant.
← all excerpts
Gut metatranscriptomics based de novo assembly reveals microbial signatures predicting immunotherapy outcomes in non-small cell lung cancer.
1
—
—